 | Viridian Therapeutics, Inc. | |||
| NCM : VRDN || Location: United States | ||||
$15.16+0.08 (+0.53%) |
0.57 M | 14.93 - 15.75 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 9.471 M |
| March 15, 2024 | 7.620 M |
| Feb. 29, 2024 | 7.574 M |
| Feb. 15, 2024 | 7.748 M |
| Jan. 31, 2024 | 8.423 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.02 | -1.35 | -31.95% |
| 09/30/2023 | -1.29 | -1.09 | 15.60% |
| 06/30/2023 | -1.32 | -1.27 | 3.82% |
| 03/31/2023 | -1.04 | -1.61 | -54.81% |
| 12/31/2022 | -0.74 | -1.13 | -52.17% |
VRDN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 62.768M | Shares Float | 47.944M |
| Short Float | 9.471M | Market Cap | 946.54M |
| Institution ownership | 0.00% | Insider ownership | 1.021% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -5.31 | Forward EPS | -4.57 |